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Abstract
Zebrafish (Danio rerio) has been used in the present work to study the fish response 
to bacterial lipopolysaccharide (LPS) exposure and LPS tolerance. These mechanisms are 
not completelly understood in mammals and, until now, totally unknown in fish. Zebrafish 
larval survival was assessed following treatment with various LPS at a variety of 
concentrations to determine the sensitivity of zebrafish to LPS-induced immune activation. 
In addition, fish pre-treated with a sublethal concentration of LPS did not die after exposure 
to a lethal concentration of LPS demonstrating, for the first time, that LPS tolerance also 
happens in fish. The time interval between pretreatment and secondary exposure as well as 
the type of pretreatment dictated the strength of protection. Since zebrafish are in intimate 
contact with microorganisms, the observed high resistance of fish to LPS suggests that 
there must be a tight control of the LPS receptor cluster in order to avoid an excess of 
inflammation. One of these components is CXCR4, which has previously been shown to 
regulate the signal transduced by TLR4. Treating fish with AMD 3100, a specific inhibitor 
of CXCR4, increased LPS treatment associated mortality. Blocking CXCR4 via chemical 
or genetic inhibition resulted in a reversion of LPS tolerance, thus further supporting the 
negative regulatory role of CXCR4 in this inflammatory response. In support of an 
inhibitory role for CXCR4 in the inflammatory cascade, IL1 transcript levels were elevated 
in both unstimulated and LPS stimulated zebrafish Odysseus (CXCR4 deficient mutant)  
larvae.
Introduction 
In mammals, microbial products such as lipopolysaccharide (LPS) or endotoxin, are 
potent inducers of inflammation that stimulates immune system cells after they are 
recognized mainly by Toll-like receptors (TLRs), a family of closely related 
transmembrane proteins that initiate signaling cascades. Gram-negative enterobacterial LPS 
signals through TLR4, which involves downstream molecules MyD88, TIRAP/Mal, IRAK 
and TRAF6, and leads to production of  proinflammatory cytokines, proteases, eicosanoids, 
and reactive oxygen and nitrogen species [1]. Gram-positive bacteria usually activate cells 
in a TLR2-dependent fashion. In the case of Pseudomonas aeruginosa LPS, the 
involvement on both TLR2 and TLR4 has been reported [2]. If the inflammatory response 
to infection is not tightly controlled, several pathological processes may develop, including 
septic shock. Although LPS-induced proinflammatory molecules such as interleukin-1 (IL-
1) or tumour necrosis factor (TNF), are important for avoiding the growth and 
dissemination of gram-negative bacteria, their overproduction can lead to endotoxin shock 
which is a severe systemic inflammatory response triggered by the interaction of LPS with 
host cells, characterized by fever, myocardial dysfunction, acute respiratory failure, 
hypotension, multiple organ failure, and in a large number of cases, death [1, 2]. It is well 
known in mammals, that a previous exposure to LPS induces "endotoxin tolerance" which 
is thought to protect the host from the endotoxic or septic shock, although the involved 
mechanisms have not been fully understood. In fact contradictory results have been 
reported. Tolerance can limit neutrophil proinflammatory responses limiting neutrophil 
responses in vivo, potentially preventing excessive cell activation [3]. 
In recent years, zebrafish (Danio rerio) has been widely used in research areas such 
as cancer, stem cell research or development, however, due to its advantages is starting to 
be used in other fields. It could also be appreciated in immunology and infectious diseases 
research: zebrafish larvae are transparent, easy to rear and only the innate immune system 
is present until several weeks postfertilization, thus simplifying analysis of immune 
responses [4]. In addition, physiological responses can be studied with the whole organism. 
Moreover, Purcell et al. [5] have characterized  the key components of the TLR-signaling 
pathway including MYD88, TIRAP, TRIF, TRAF6, IRF3, IRF7 in zebrafish. It is also 
already reported that the main receptor for LPS is expressed in zebrafish at early times of 
infection [6, 7], however, accessory molecules such as CD14, that are essential for the 
response to LPS in mammals, seem not to be present in the zebrafish genome [8].
The SDF1-CXCR4 system plays a role in hematopoietic cell migration during 
mammalian development [9] and recently has been implicated in germ cell and neuronal 
migration in developing zebrafish [10- 13]. Cell migration is not only involved in aspects of 
development, organogenesis and organ function, but also plays a role in several 
pathological processes, such as the spread of tumour cells and formation of metastases [9] 
and the inflammatory  responses. In fact, CXCR4 belongs to the cluster that participates in 
the LPS recognition after LPS binding protein and CD14 transfers the LPS from the 
extracellular space to the membrane, probably inhibiting the TLR4 in order to control an 
excess of inflamatory response [14]. 
In this work we have explored the use of zebrafish larvae as a new model for the 
study of LPS exposure associated mortality and LPS tolerance which is a hypo-responsive 
state to a second exposure to LPS. The advantages of using zebrafish, highly appreciated in 
other fields such as stem cells research, development and cancer, are also very useful for 
the study of immune response against infections.
Material and methods
Zebrafish and embryos were maintained according to standard protocols [15]. 
Odysseus mutants [11], which have a mutation in the CXCR4 gene, were also maintained 
according to standard protocols. All the mortality experiments were conducted using 
replicates of 10-15 fish each. Fish were maintained in 6 wells plates at 28 ºC during the 
treatments. 
Zebrafish larvae were bathed in a range of concentrations of Escherichia coli
0111:B4, P. aeruginosa LPS (Sigma). Zebrafish larvae of 2, 5 and 10 days post fertilization 
(dpf) were treated with 0, 5, 25, 50, 150 and 200 µgr/ml of 0111:B4 E. coli LPS. The same 
concentrations were used for Pseudomonas aeruginosa LPS (Sigma) Mortality was 
recorded regularly for 48 hours. 
Tolerance experiments were conducted using two days larvae that were exposed to 
sublethal LPS concentrations (50 µg/ml of E. coli 0111:B4 or 2,5; 5 and 10 µg/ml of P. 
aeruginosa). At different times post treatment, larvae were exposed to a lethal 
concentration of E. coli 0111:B4 or P. aeruginosa LPS. 
Cross tolerance experiments were conducted using one or two pretreatments of 50 
µg/ml of different PAMPs (E. coli 0111:B4 LPS, E. coli 055: B5 LPS (Sigma), P. 
aeruginosa LPS,  glucans (Macrogard), lipoteichoic acid from Staphylococcus aureus
(Sigma), poly I:C (Sigma)) followed by a lethal concentration of E. coli LPS (150 µg/ml).
To investigate the involvement of CXCR4 on the larvae response to LPS, treatments 
with AMD3100 (Sigma) which is a pharmacological specific CXCR4 inhibitor, were 
studied. In order to find a non toxic concentration for zebrafish larvae several 
concentrations were assayed (1 ng/ml, 10 ng/ml, 100 ng/ml, 1 µg/ml, 10 µg/ml, 100 µg/ml). 
Treatments with AMD 3100 alone or combined with a sublethal LPS pretreatment, 
previous to a lethal LPS concentration exposure, were used. Zebrafish Odysseus mutants, 
which have a mutation in the CXCR4 gene, were also used to clarify CXCR4 role in LPS 
tolerance.
Quantitative PCR assays were performed using the 7300 Real Time PCR System 
(Applied Biosystems) using pooled samples of 4-5 fish larvae. cDNA amplification was 
performed using specific primers designed by Primer 3 software [16]. 0.5 l of each primer 
(10 M) was mixed with 12.5 l of SYBR green PCR master mix (Applied Biosystems) in 
a final volume of 25 l. The standard cycling conditions were 95 º for 10 min, followed by 
40 cycles of 95º 15 s and 60 º for 1 min. The comparative CT method (2-ΔΔCT method) 
was used to determine the expression level of analyzed genes [17]. The expression of the 
candidate genes was normalized using –actin as a housekeeping gene. IL-1 was amplified 
with primers Forward ATC TCC ACC ATC TGC GAA TC and Reverse: AAC CTG TAC 
CTG GCC TGT TG and –actin was amplified with primers: Forward: CAA CGG AAA 
CGC TCA TTG C and Reverse: CGA GCA GGA GAT GGG AAC C. Data were analyzed 
using a Student's t-test and differences were considered statistically significant at p<0.05.
Results
1. Mortality caused by LPS exposure. 
Only the highest concentrations (150 and 200 µg/ml) of E. coli 0111:B4 were able 
to induce zebrafish larvae mortalities (Figure 1). However, LPS from Pseudomonas 
aeruginosa, was able to kill the fish at lower concentrations (50-100 µg/ml) than E. coli 
LPS (Figure 2).
The final E. coli LPS concentrations of 150 µg/ml or 50 -100 µg/ml of P. 
aeruginosa were reproducibly  lethal concentrations for wild type zebrafish embryos. 
2. Induction of tolerance using LPS and pathogen associated molecular patterns 
(PAMPs).
In order to know if low LPS concentrations could produce tolerance in zebrafish, 2 
dpf embryos were first treated with a sublethal concentration of 50 µg/ml of E. coli
0111:B4 LPS followed by a exposure to a lethal concentration of the same LPS serotype. 
The timing of administration of sublethal and lethal concentrations was critical (Figure 3). 
Tolerance was always observed when the time interval between pretreatment with the 
sublethal and exposure to the lethal concentration was at least 24 hours. Exposure to a 
sublethal treatment 6 h before the exposure to the lethal concentration was not sufficient to 
confer protection. On the contrary, tolerance was observed when 4 days was the difference 
between treatments with the sublethal and lethal concentrations. 
In all the conducted experiments, tolerance was always observed when LPS from E. 
coli 0:111 was used as sublethal concentration one day before of a lethal concentration of 
E. coli LPS (150 µg/ml) or Pseudomonas LPS (50-100 µg/ml). However, tolerance was not 
observed when larvae were pretreated with sublethal concentrations of Pseudomonas LPS 
(data not shown). 
Other PAMPs (pathogen associated molecular patterns) were investigated to 
determine their ability to induce cross tolerance (protection) to LPS exposure. While some 
protection was observed with a single pretreatment, two treatments of 50 µg/ml of each 
PAMP were more effective in the induction of tolerance (Figure 4). In this case, LTA and 
the two E. coli LPS produced a complete protection of fish and poly I:C induced a delay in 
mortalities caused by a lethal concentration of LPS. 
IL-1 transcript levels increased with time in larvae following a lethal exposure to 
LPS (Figure 5). A decrease in IL-1 transcript levels was observed in larvae treated with a 
sublethal concentration after 3 h. 
3. CXCR4 involvement on the response to LPS treatment (AMD3100 treatment and 
Odysseus mutant fish).
With the aim to determine if CXCR4 has a role in the LPS tolerance of fish, we 
blocked its function via chemical and genetic approaches. First, after using a range of 
several concentrations of AMD3100, a pharmacological specific CXCR4 inhibitor [18, 19], 
we found that the 10 µg/ml concentration was non toxic for zebrafish larvae). Larvae 
exposed to AMD3100 were more sensitive to LPS treatment; lower concentrations of LPS 
led to lethality in the presence of AMD3100 (Figure 6A). Moreover, fish receiving 
AMD3100 treatment during the tolerization period were not able to survive after the 
exposure to a lethal concentration of LPS although they were treated previously with a 
protective sublethal concentration of LPS as in the experiments already described (Figure 
6B). 
Odysseus mutants, which are mutated in the CXCR4 gene, did not show higher 
sensitivity to LPS, but no LPS tolerance was observed (Figure 6B). To directly test the 
effect of CXCR4 loss-of-function on the downstream effects of the inflammatory cascade, 
IL-1 transcript levels were determined in Odysseus mutants before and after a sublethal 
exposure to LPS (Figure 6C). IL-1 levels were found to be high in Odysseus mutants 
without LPS exposure and additionally a significant increase in IL-1 level was seen in 
Odysseus mutants following treatment. 
Discussion
The inflammatory cascade begins with the receptors involved in the binding and 
uptake of bacteria and their products by cells of the innate immune system. It continues 
with the production of proinflammatory cytokines, such as TNF-, IL-1, and IL-8, lipid 
mediators, oxygen radicals, and tissue-damaging enzymes [20]. In this work we have 
shown that from an early age, zebrafish larvae (2dpf) are able to produce an inflammatory 
response when exposed to LPS. 
The minimum lethal LPS concentration was much higher than in mammals and this 
led us to wonder why and how fish are so resistant to LPS and in general to other PAMPs 
as it has also been reported [8, 21- 23]. Although resistance to LPS has been observed in 
other non-mammalian vertebrates [8, [24], fish live in water and therefore in intimate 
contact with a potentially high amount of microorganisms. If a high inflammatory reaction 
was triggered after each contact with external putative pathogens, fish simply could not 
survive. Thus, inflammation and sepsis should be tightly regulated in these animals due to 
their environment placement.
In agreement with it was reported for mammals [25] P. aeruginosa LPS was more 
lethal than E coli LPS. Interestingly, the pretreatment of zebrafish larvae with different P. 
aeruginosa LPS concentrations did not protect to the subsequent exposure with a lethal 
concentration with same LPS. On the contrary, the preteatment with a non lethal LPS (E. 
coli) did protect when fish were exposed to the P. aeruginosa LPS. This needs further 
research to clarify the involved molecular mechanisms. 
As observed in mammalian macrophages, exposure of zebrafish larvae to high 
concentrations of LPS produces an excess of proinflammatory cytokines and other 
molecules which leads to death. However, if the fish are first treated with a sublethal 
concentration, this induces a hypo-responsive state to a second treatment of LPS that is 
known as LPS tolerance. TLR homotolerance is consistently stronger than TLR 
heterotolerance (with other different PAMPs) [26]. This agrees with our experiments since 
although we could detect a complete protective role after two administrations of 
lipoteichoic acid (component of the surface of Gram-positive bacteria) to an exposure of a 
lethal concentration of LPS, this was not observed when only one pretreatment was given. 
However, no protection was achieved when glucan was used; this molecule interacts 
with a signalling non-TLR pattern-recognition receptor, dectin-1,
but whether this is the cause of the lack of protection 
observed needs further research. Poly I:C, which mimics a viral infection, 
showed an intermediate effect. These different responses are incompletely understood 
mechanisms in mammals and, until now, totally unknown in fish.
IL-1 has been involved as a mediator of tolerance in vivo in mammals [27]. Our 
results show that the expression of IL-1 increases when fish are treated with high LPS 
concentrations, which would imitate the over-production of proinflammatory cytokines that 
is produced in the cases of sepsis. However, IL-1 decreases in the hypotolerized state 
induced by lower LPS concentrations which is in agreement with the reported inhibited 
expression of many cytokines, e.g., TNF, IL-1ß, IL-6, and IL-12 in cases of LPS tolerance 
[28].
Several studies have pointed out that the chemokine receptor CXCR4 seems to be a 
functional part of the LPS-sensing apparatus [14, 27], and could have a role inhibiting the 
signaling cascade initiated by TLR4. In the Odysseus fish, in which CXCR4 function is 
inhibited, the expression of IL-1 was higher than in wild types in the unstimulated state and 
was increased even more when fish were treated with LPS. 
When wild type zebrafish larvae were treated with a AMD3100, a pharmacological 
specific CXCR4 inhibitor [18, 19] no tolerization was obtained. Similar results were 
obtained on Odysseus fish. These observations strongly suggest that CXCR4 could have a 
key role in modulating zebrafish immune response to endotoxin LPS, since CXCR4 
impairment (genetic or pharmacological) induces higher inflammatory responses and 
reversion of tolerance. These results suggest that zebrafish may have experienced an 
evolutionary selective pressure to avoid excessive inflammatory states that might be 
associated with an increased activity of the CXCR4 receptor. Our findings agree with 
previous studies, in which CXCR4 is described as involved in LPS binding but also 
responsible for the triggering signalling. However, there is a controversy on this subject 
since some authors find that CXCR4 acts as an inhibitor of the LPS receptor TLR4 [29], 
but others state that CXCR4 interacts with TLR4 augmenting the LPS signalling [30].
Zebrafish might be a good model for studying infectious diseases, septic shock and 
tolerance to endotoxin. Zebrafish has several advantages compared with other models: a 
high number of individuals can be used, the availability of transgenic or mutant fish, and 
the ease of chemical manipulation, all of which allow facile observations of whole 
organism inflammatory reaction to external stimuli. This is a substantial benefit compared 
to other studies where only a cell line can be evaluated, and thus may not mirror the true in 
vivo response. 
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Figure Legends
Figure 1. Survival of zebrafish larvae exposed at different days post fertilization (dpf) to E. 
coli 0111:B4 LPS. Fish were bathed direcly in water with the different LPS concentrations. 
Data correspond to a representative experiment conducted 4 times.
Figure 2. Zebrafish larvae survival exposed at 2 dpf with Pseudomonas aeruginosa LPS. 
Results are + standard deviations (n= 2 replicates with 15 fish each) of a representative 
experiment repeated three times. 
Figure 3. Summary of the different experiments conducted to demonstrate LPS tolerance in 
zebrafish. 2 dpf embryos were treated with a sublethal concentration of LPS (50 µg/ml of 
E. coli 0111:B4) and then at different times postinfection, a exposure to a lethal 
concentration (150 µg/ml) of the same LPS was conducted. 
Figure 4. Survival of zebrafish larvae incubated with other PAMPS to determine if they can 
induce tolerance to LPS. Treatments with the lethal concentration of E. coli LPS were 
conducted at 7 dpf. (A) one pretreatment at 3 dpf (B) two pretreatments at 3 and 6 dpf of 
PAMPs or two E. coli LPS serotypes. Results are + standard deviations of n= 2 replicates 
from a representative experiment out of three.
Figure 5. Expression of IL-1 by qPCR showing its decrease after exposure to sublethal E. 
coli LPS concentration (50 µg/ml) compared with its increment when a lethal concentration 
was used (150 µg/ml). Results are + standard deviations of n= 4 pooled samples. *: 
indicates significant differences, p<0.05, with respect to control. #: indicates significant 
differences , p<0.05, with respect to the initial value after 30 minutes of treatment.
Figure 6. Involvement of CXCR4 on the sensitivity to LPS and tolerance.
(A) Survival of wild type fish treated with AMD3100, a specific CXCR4 inhibitor, showing 
that AMD3100 treated fish do not survive to LPS sublethal concentrations. Results are +
standard deviations (two replicates with 10 fish each). (B) Reversion of the tolerance to 
LPS in Odysseus fish and AMD3100 wild type treated fish compared with untreated wild 
type zebrafish. Fish were treated with a sublethal concentration of LPS and after one day 
they were exposed to a lethal concentration of P. aeruginosa. Results are + standard 
deviations (two replicates with 10 fish each). (C) qPCR of IL-1 of Odysseus and Tubingen 
(wild type) fish 24 hours after the treatment with 50 µg/ml of LPS. Results are + standard 
deviations of n= 4 pooled samples. *: indicates significant differences, p< 0.05, with 
respect to controls. 
Fig 1.
2 dpf fish treated with E. coli  LPS
0
20
40
60
80
100
120
0 6 20 30
Hours post-treatment
0 µg/ml
5 µg/ml
25  µg/ml
50  µg/ml
150 µg/ml
200 µg/ml
5 dpf fish treated with E. coli  LPS
0
20
40
60
80
100
120
0 6 20 30
Hourst post-treatment
0 µg/ml
5 µg/ml
25  µg/ml
50  µg/ml
150 µg/ml
200 µg/ml
10 dpf fish treated with E. coli  LPS
0
20
40
60
80
100
120
0 6 20 30
Hours post-treatment
0 µg/ml
5 µg/ml
25  µg/ml
50  µg/ml
150 µg/ml
200 µg/ml
Figure 1
Fig 2.
Survival of zebrafish treated with P. 
aeruginosa  LPS
0
20
40
60
80
100
120
0 h 3 h 6 h 8 h 24 h 72 h
Hours post-treatment
200 µg/ml
150 µg/ml
100 µg/ml
50 µg/ml
25 µg/ml
10 µg/ml
Control
Figure 2
Fig. 3
Fertilization Subletaldose
Letal
dose Mortalities
Fertilization Subletaldose
Letal
dose Mortalities
Fertilization Subletaldose
Letal
dose Mortalities
Fertilization Subletaldose
Letal
dose Mortalities
2 days
2 days
2 days
2 days
6 h
1 day
2 days
4 days
1 day
1 day
1 day
1 day
Controls: 100%(+0) mortality
Treated: 100%(+0) mortality No Tolerance
Controls: 100%(+0) mortality
Treated: 0% (+0) mortality Tolerance
Controls: 100%(+0) mortality
Treated: 0% (+0) mortality Tolerance
Controls: 100%(+0) mortality
Treated: 2% (+2,8) mortality  Tolerance
Figure 3
Fig 4.
 2 pretreatments
0
10
20
30
40
50
60
70
80
90
100
0 h 3 h 6 h 8 h 24 h
Time post LPS exposure
Control
Gluc
Poly I:C
A. Lipot.
 E coli 055
 E coli 0111
1 pretreatment
0
20
40
60
80
100
120
140
0 h 3 h 6 h 8 h 24 h
Time post LPS exposure
Control
Gluc
Poly I:C
A. Lipot.
 E coli 055
 E coli 0111
Figure 4
Fig 5.
0
0,0000005
0,000001
0,0000015
0,000002
0,0000025
0,000003
0,0000035
Control LPS 50 LPS 150
q
P
C
R
 e
xp
re
ss
io
n
 v
al
u
es
30m
1 h
3 h
* #
#
Figure 5
Fig 6. 
0
20
40
60
80
100
120
0 min 30 min 1 h 3h 5 h 24 h
Time post treatment
0 _g/ml
10 _g/ml
25 _g/ml
50 _g/ml
100 _g/ml
A
B
0
20
40
60
80
100
120
2 h 3 h 4 h 20 h 24 h 30 h
Time post challenge
Wild Type fish
Odysseus fish
AMD treated fish
C
0
0,0005
0,001
0,0015
Control LPS Ody Control Ody LPS
Wild type fish               Odysseus fish
*
*
Figure 6
